Novus Therapeutics Inc. (NVUS) Fell -6.59% or -0.18 To Price $2.55 On Friday


Novus Therapeutics Inc. (NVUS) fell -6.59% or -0.18 to $2.55. It is nearly 157658 shares traded, which is 379.46% compare to the average total volume 41548. The market cap of NVUS is $24.06 million. The year to date change is 57.86%. The 52 week price range is from $1.52 to $8.61. Price of NVUS have changed -9.00% during last week. It have changed -32.09% over last month, 5.00% over last 3 months, -17.77% over last 6 months and -38.10% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NVUS is 4.06. It is 59.22% above current price. The 200-day Moving Averages for NVUS is 4.14. It is 62.35% above current price. The 52-week High is 8.61. It is 237.65% from the current price. The 52-week Low is 1.52. It is -40.39% from current price.

There are some statistics of NVUS. It is has market cap $24.06 million. The share outstanding is 9.43 million. The average volume is 41548. The percent of top 15 Institution holding is 36.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NVUS is -84.95%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NVUS is -75.98%.


Tags:

Share this post